Thomas O. Daniel - Concepedia

Author

Thomas O. Daniel

Also Known As

T O Daniel, T OʼConnor Daniel, T. O. Daniel, T.O. Daniel, THOMAS O. DANIEL, Thomas Daniel, Thomas O Daniel, Thomas O. Daniel

Publications

9.9K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Howard Hughes Medical Institute Vanderbilt University Medical Center University of California, San Francisco IDEX Corporation (United States)

About

Thomas O. Daniel is an author at Vanderbilt University specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	27	5.6K
2	Natural Sciences	5	5	1.3K
3	Biochemistry	4	4	484
4	Health Sciences	3	3	588
5	Engineering	2	2	283

Thomas O. Daniel

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors Yosef Yarden, J A Escobedo, Wun-Jing Kuang, Nature ThrombopoiesisSignal TransductionDevelopmental BiologyBlood PlateletGrowth Hormone	1986	1.2K
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase Mary E. Matyskiela, Gang Lu, Takumi Ito, Nature Protein FunctionSignal TransductionCell RegulationCrl4crbn Ubiquitin LigaseNatural Sciences	2016	628
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp> Anita K. Gandhi, Jian Kang, Courtney G. Havens, British Journal of Haematology	2013	611
The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity Christina Addison, Thomas O. Daniel, Marie D. Burdick, The Journal of Immunology	2000	570
Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs Philip P. Chamberlain, Antonia Lopez‐Girona, Karen Miller, Nature Structural & Molecular Biology Molecular PharmacologyNatural SciencesMolecular BiologyMolecular BasisChemical Biology	2014	499
Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses Elke Stein, Andrew A. Lane, Douglas Pat Cerretti, Genes & Development	1998	423
Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 Maria Grazia Lampugnani, Adriana Zanetti, Monica Corada, The Journal of Cell Biology	2003	403
A Novel TNF Receptor Family Member Binds TWEAK and Is Implicated in Angiogenesis Steven R. Wiley, Linda Cassiano, Timothy Lofton, Immunity Signal TransductionAngiogenesisSignaling PathwayReceptor Tyrosine KinaseT-regulatory Cell	2001	376
Antiphosphotyrosine Recovery of Phospholipase C Activity After EGF Treatment of A-431 Cells Matthew I. Wahl, Thomas O. Daniel, Graham Carpenter Science Epidermal Growth FactorPhospholipase C ActivityPathologyCell GrowthCellular Physiology	1988	321
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Thomas O. Daniel, Hua Liu, Jason D. Morrow, PubMed Vascular DiseaseThromboxane A2Endothelial MigrationOxidative StressInflammation	1999	295

Page 1